Pfizer’s positive antiviral news raises hopes for a new easy-to-take treatment for COVID-19, and cases start to rise again in California

Pfizer shares soared Friday after the company released interim data from a late-stage trial of its COVID-19 antiviral that showed it to be highly effective, raising hopes that a new treatment for the virus that is easy to administer may soon be allowed.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.